Navigation Links
MiMedx Announces Next Steps After Discussions With The FDA
Date:12/4/2013

ded Taylor.

About MiMedx   
MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include AmnioFix® and EpiFix®, our tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® process, to produce a safe and effective implant. MiMedx® is the leading supplier of amniotic tissue, having supplied over 200,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

Safe Harbor Statement   
This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes.  Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to, the Company's ability to reach agreement with the FDA on a transition plan, the Company's ability to successfully complete the IND/BLA process for one or more applications, the Company's ability to continue marketing its micronized products, the Company's ability to achieve the 2013 and 2014 revenue projections and that such projections are not dependent on the micronized products, the clinical and cost effectiveness of the Company's products, and the effect of the CMS final rule regarding packaging skin substi
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
2. MiMedx Group to Present at the 6th Annual OneMedForum
3. MiMedx Announces 2012 Results
4. MiMedx Group, Inc. Announces Release Date for 2013 Second Quarter Results
5. MiMedx Addresses FDA Untitled Letter And Reiterates 2013 And 2014 Guidance
6. MiMedx Announces Conference Call To Discuss FDA "Untitled Letter" And Reiterate Guidance
7. MiMedx to meet with FDA in Mid-October
8. Seven Poster Abstracts Highlight MiMedx Allografts at the 10th Annual Desert Foot Conference
9. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
10. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
11. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss its second quarter ... its development programs for ThermoDox®, its proprietary heat-activated ... technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy and ... August 10, 2015. To participate in the call, ...
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, Inc. ... Dr. Daniel Teper , will present live at ... 6, 2015 TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... interactive online event where investors are invited to ask ... presentation hall as well as the association,s "virtual trade ...
(Date:8/3/2015)... 2015  Encision Inc. (PK:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 30, 2015. The Company posted quarterly net ... of $213 thousand, or $(0.02) per share. These results ... net loss of $202 thousand, or $(0.02) per share, ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5
... announces that a new market research report is ... Outlook for Pharmaceuticals in Central Asia ... for Pharmaceutical Markets in Asia is a unique ... Each report provides individual and highly-detailed analysis of ...
... Reportlinker.com announces that a new market research report ... The Market for Pharmaceuticals in Brazil, Russia, India ... Evaluate the status, opportunities and threats ... China now and in the future. Market forecasts ...
Cached Medicine Technology:Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 3Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 2Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 3Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 4Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 5
(Date:8/3/2015)... ... August 03, 2015 , ... Results of a comprehensive ... Healthcare Research and Policy Analysis show widespread support for the U.S. Affordable Care ... or strongly agreed that the controversial law passed in 2010 had “more good ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... to Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. ... water aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... A ... Pain: Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For ... in patients. According to the report, the new study showed that harvesting stem cell-rich ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dignity Health ... Health Arizona General Hospital Emergency Room – Gilbert, opening in August. The new ... this year in the West Valley. , “Dr. Baldwin is an excellent leader ...
(Date:8/3/2015)... ... 2015 , ... Cambia Health Solutions has promoted Scott Powers ... Medicare and Federal Employee Programs (FEP) lines of business. , Government programs ... In this role, Scott is responsible for overseeing the growth, finance and operations ...
Breaking Medicine News(10 mins):Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2
... HealthDay Reporter , MONDAY, Dec. 12 (HealthDay News) -- When ... a pound, Madeline Mann was the world,s smallest surviving baby. ... title of world,s tiniest infant, weighing in at 0.57 pounds. She ... ventilator in the neonatal intensive care unit at Loyola University Medical ...
... University of Georgia and the Mayo Clinic in Arizona have ... model that mimics 90 percent of human breast and pancreatic ... The vaccine, described this week in the early ... of Sciences , reveals a promising new strategy for treating ...
... MONDAY, Dec. 12 (HealthDay News) -- Breast reconstruction is ... mastectomy, according to a new study. Mastectomy is ... of a breast has implications for the psychological, social ... that reconstruction should be offered," Dr. Marissa Howard-McNatt, an ...
... have created a deck of cards with conversation starters ... parents can use to guide their discussions when talking ... Researchers in the Faculty of Medicine & Dentistry at ... on their findings in a recently published paper in ...
... resistance to brain tumor chemotherapy Glioblastoma multiforme ... human brain tumors that originate in the brain. For ... therapy and chemotherapy with temozolomide. However, many GBMs are ... researchers led by Sameer Agnihotri, at the University of ...
... Reporter , MONDAY, Dec. 12 (HealthDay News) -- An advisory panel ... the Ortho Evra birth control patch carries a higher risk of ... be taken off drug store shelves. The panel, which based ... data, voted 19 to 5 that the benefits of Johnson & ...
Cached Medicine News:Health News:World's Tiniest 'Preemies' Growing Up Healthy: Report 2Health News:World's Tiniest 'Preemies' Growing Up Healthy: Report 3Health News:Scientists develop vaccine that attacks breast cancer in mice 2Health News:Scientists develop vaccine that attacks breast cancer in mice 3Health News:Scientists develop vaccine that attacks breast cancer in mice 4Health News:After Mastectomy, Breast Reconstruction Is Safe for Older Women 2Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 2Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 3Health News:JCI online early table of contents: Dec. 12, 2011 2Health News:JCI online early table of contents: Dec. 12, 2011 3Health News:JCI online early table of contents: Dec. 12, 2011 4Health News:JCI online early table of contents: Dec. 12, 2011 5Health News:JCI online early table of contents: Dec. 12, 2011 6Health News:JCI online early table of contents: Dec. 12, 2011 7Health News:JCI online early table of contents: Dec. 12, 2011 8Health News:JCI online early table of contents: Dec. 12, 2011 9Health News:FDA Panel Cites Clot Risk From Contraceptive Patch 2
... monitor offers a comprehensive array of features ... pediatric and neonate patients, to magnetic resonance ... is the first MR monitor designed to ... neonate patient monitoring. The new monitor is ...
... specific antigen (PSA) is a serine protease that ... epithelial cells of the acini and ducts. Normal ... 0.1-2.6 ng/mL. Reports have suggested that elevated level ... must useful tumor markers in diagnosis of prostate ...
... in vitro assay for detection of alpha ... is a protein with molecular mass ranging ... concentration in serum is below 9 ng/mL; ... ovarian, testicular and presacral teratocarcinomas, and other ...
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
Medicine Products: